Immune to Cancer: The CRI Blog
-
CICON19 Day 3 Update: Vaccines and Tumor Antigens, Technology and Informatics, and the Tumor Microenvironment
Day 3 of CICON19 explored current strategies to identify tumor neoantigens and develop vaccines as well as advances…
-
CICON19 Day 1 Update: Cancer Prevention and Combination Immunotherapy Strategies
Day 1 of CICON19 explored how checkpoint immunotherapy might be improved through combination strategies as well as…
-
Childhood Cancer Awareness Month: 2019 Immunotherapy Research Update
For Childhood Cancer Awareness Month, we round up the latest news and research from the people changing…
-
Documentary Highlights Life and Work of CRI’s Dr. James Allison, 2018 Nobel Laureate
A new documentary on the life and work of Dr. James Allison, 2018 Nobel Prize winner and…
-
Blood Cancer Awareness Month: 2019 Immunotherapy Research Update
For Blood Cancer Awareness Month, we round up the latest news and research from the people changing…
-
How Immunotherapy is Impacting Pediatric Cancer
We spoke with Susanne Baumeister, MD, about the current treatment landscape in childhood cancer, including immunotherapy and…
-
The Promise of CAR T Cell Therapy in 2019 and Beyond
Dr. Michel Sadelain discusses what’s next in CAR T cell therapy, including the remarkable benefits and the…
-
CICON19 Preview: Translating Science into Survival
Topics at the upcoming CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (CICON19) in Paris include prevention, the tumor microenvironment,…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.